Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Platform
- Language
- Publication Date
1 - 20 of 24 results
Applied Filters
必威体育登录手机This application note introduces a method for target capture (long-read) sequencing using the Agilent SureSelect XT HS2 target enrichment system with some protocol modifications.
必威体育登录手机Unlock the full potential of comprehensive genomic profiling (CGP) to advance precision oncology with the Agilent SureSelect Cancer CGP Assay, a targeted, pan-cancer panel based on next-generation sequencing.
Offers customized genomic profiling of cancer samples with custom NGS panels, which can incorporate new and emerging biomarkers.Enables assessment of CNVs, SNVs, indels, translocations, TMB, MSI.
User Guide for SureSelect Cancer CGP Assay and SureSelect Cancer Tumor-specific Assays.
Provides SureSelect XT HS2 index sequences in Excel format.Click the Sequence Resource link to download the .xlsx file to your local device (typically Downloads folder).
Offers tumor-specific profiling of lung, colon, pancreas, kidney, and bladder with NGS panels of globally curated genes sourced from cancer databases.Enables detection of CNVs, SNVs, indels, translocations.
Offers genomic profiling of cancer samples with a NGS panel of globally curated genes sourced from cancer databases.Enables detection of CNVs, SNVs, indels, translocations, gene fusions as well as TMB & MSI.
Protocol for SureSelect XT HS Target Enrichment System
必威体育登录手机Optimization of an Agilent NGS Automated Workflow for the Characterization of NSCLC DNA Samples in a Molecular Diagnostic and Anatomic Pathology Laboratory
"Many types of cancers are caused by either inherited or de novo genomic abnormalities such as single-nucleotide variants (SNVs), copy number variations (CNVs), and/or chromosomal translocations."
Brochure on SureSelect Cancer All-In-One Catalog and Custom Assays
Overview of the SureSelect Cancer All-In-One workflow
SureSelect Cancer All-in-One solid tumor assay enables the detection of SNVs, indels, CNVs and translocations in genes relevant to common tumor types.This assay requires a single genomic DNA and is compatible with FFPE tumor samples.
必威体育登录手机Agilent community designs are NGS panels and microarrays created by our customers and deployed successfully in their laboratories and are now available to you.
One assay, all lung cancer-relevant variants in a single DNA workflow
必威体育登录手机The Agilent Avida DNA cancer panels are optimized for sensitive and innovative target enrichment applications such as liquid biopsy and multiomics sequencing.
必威体育登录手机Agilent SureSelect CD TagTile panel for hybrid targeted RNA capture.
必威体育登录手机Flyer-Agilent SureSelect CD HRR17 Panel
Flyer SureSelect CD HMH Myeloid Cancer Panel Flyer
University of Nantes Hospital Center team developed the SureSelect CD ONCOgenes CAPture Haemoclonality Panel to detect lymphoid clonality alongside genetic alterations in the oncogenes assayed.